Cann Group revenue climbs 83% but losses deepen to A$18.8 million by Steve Jones February 24, 2023April 30, 2024 Losses at Cann Group more than doubled in the first half of the 2023 financial year […]
‘We’re not giving up,’ says new Cann Group CEO as researchers pore over clinical trial results by Steve Jones January 24, 2023March 13, 2023
Cann Group COO Shane Duncan quits after four ‘challenging and exciting years’ by Steve Jones January 23, 2023January 23, 2023
Sleepless nights ahead for Cann Group as over-the-counter CBD trial fails the placebo challenge by Steve Jones January 19, 2023January 19, 2023